Mid-Day Breakouts Report - Wednesday, March 4th, 2020

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, February 25, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - WEDNESDAY, MARCH 4TH, 2020
Previous Mid Day Report Next Mid Day Report >>>

DOW 26381.66 464.25 (1.79%) | NASDAQ 8796.58 112.49 (1.30%) | S&P 500 3048.85 45.48 (1.51%)

Time of Screening : 3/4/2020 10:58:10 AM Report Released : 3/4/2020 11:20:20 AM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 45% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Pivot Point
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Max Buy
STNE - NASDAQ Stoneco Ltd Cl A	$43.43	-0.86 -1.94%	$44.29	1,469,610 71.97% of 50 DAV 50 DAV is 2,042,000	$46.69 -6.98%	1/22/2020	$43.94	PP = $45.72 MB = $48.01
Most Recent Note - 3/4/2020 11:16:20 AM Y - Sputtering today after touching a new all-time high on the prior session with a 4th volume-driven gain in the span of 5 sessions. Volume-driven gain helped it promptly rebound above its 50 DMA line ($41.83). Reported earnings +71% on +43% sales revenues for the Dec '19 quarter, continuing its strong earnings track record. The worrisome market correction (M criteria) is cause for concern, even if there are subsequent gains above the pivot point backed by at least +40% above average volume to trigger a technical buy signal. >>> The latest Featured Stock Update with an annotated graph appeared on 3/2/2020. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
BTG - NYSE - Mining-Gold/Silver/Gems B2Gold Corp	$4.29	+0.00 0.00%	$4.38	$4.93	-12.98%	3,611,525 45.66%	7,909,000
Most Recent Note for BTG - 3/4/2020 10:59:16 AM Rebounded above its 50 DMA line. Reported Dec '19 earnings +17% on +36% sales revenues. Prior mid-day reports repeatedly cautioned members - "Quarterly earnings comparisons through the Sep '19 quarter have been below the +25% minimum guideline (C criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
BTI - AMEX - TOBACCO - Cigarettes British Amer Tobacco Adr	$40.67	+0.91 2.28%	$40.96	$45.64	-10.90%	780,721 51.23%	1,524,000
Most Recent Note for BTI - 3/4/2020 10:59:51 AM Prior mid-day reports noted - "Quarterly comparisons show sub par sales revenues and earnings increases, not a match with the fact-based system's fundamental guidelines. Its annual earnings history has been slow and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CI - NYSE - Medical-Managed Care Cigna Corp	$208.37	+19.12 10.10%	$211.94	$224.64	-7.24%	2,875,923 139.27%	2,065,000
Most Recent Note for CI - 3/4/2020 11:00:36 AM Tested support at its 200 DMA line. Prior mid-day reports noted - "Reported a strong +75% earnings increase on +167% sales revenues for the Dec '19 quarter. Prior quarterly comparisons had sub par earnings increases below the +25% minimum guideline (C criteria). Annual earnings growth (A criteria) has been strong after a downturn in FY '16."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CP - NYSE - TRANSPORTATION - Railroads Canadian Pacific Railway	$250.50	+2.61 1.05%	$254.67	$275.13	-8.95%	198,453 49.37%	402,000
Most Recent Note for CP - 3/4/2020 11:01:28 AM Slumped from its all-time high and found support at its 200 DMA line after a streak of volume-driven losses. Reported earnings +5% on +3% sales revenues for the Dec '19 quarter and fundamental concerns remain.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
DGX - NYSE - HEALTH SERVICES - Medical Laboratories & Researc Quest Diagnostics Inc	$111.95	+3.30 3.04%	$113.34	$113.97	-1.77%	478,379 51.61%	927,000
Most Recent Note for DGX - 3/4/2020 11:02:55 AM Perched near its 52-week high after testing support at its 200 DMA line. Fundamentally, sales revenues and earnings history is not a match with the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GOLD - NYSE - METALS & MINING - Gold Barrick Gold Corporation	$20.23	-0.40 -1.92%	$21.05	$22.57	-10.39%	7,584,782 52.04%	14,576,000
Most Recent Note for GOLD - 3/4/2020 11:04:10 AM Found prompt support at its 50 DMA line ($18.84). Prior mid-day reports noted - "The Jun, Sep, and Dec '19 quarterly comparisons showed greatly accelerating sales revenues and earnings growth above the +25% minimum earnings guideline (C criteria). Up and down annual earnings (A criteria) history is a flaw. It was dropped from the Featured Stocks list on 3/14/12."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HUM - NYSE - HEALTH SERVICES - Health Care Plans Humana Inc	$364.35	+38.98 11.98%	$371.00	$385.00	-5.36%	1,390,906 130.11%	1,069,000
Most Recent Note for HUM - 3/4/2020 11:06:59 AM Rebounding near its all-time high after abruptly retreating to test its 200 DMA line. Reported earnings -14% on +15% sales revenues for the Dec '19 quarter, its 2nd comparison below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IESC - NASDAQ - Bldg-Maintenance & Svc Integrated Electric Svcs	$24.37	+1.04 4.46%	$24.46	$27.78	-12.28%	17,570 58.57%	30,000
Most Recent Note for IESC - 3/4/2020 11:07:21 AM Sputtering below its 50 DMA line ($25.40) after retreating from multi-year highs. Reported earnings +35% on +13% sales revenues for the Dec '19 quarter. Three of the past 4 quarterly earnings were above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) is a fundamental flaw.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
JD - NASDAQ - Retail-Internet JD.com Inc Cl A Ads	$43.95	+2.49 5.99%	$44.76	$44.12	-0.40%	9,783,028 72.89%	13,421,000
Most Recent Note for JD - 3/4/2020 11:07:46 AM Found prompt support near its 50 DMA line ($39.40) and powered to a new 52-week high with a big volume-driven gain. Noted with caution in prior mid-day reports "Faces resistance due to overhead supply up to the $50 level. Noted with caution in prior mid-day reports - 'Its 200 DMA line ($30) acted as support in recent months when consolidating. This Chinese retailer reported greatly improved earnings increases in the 4 latest quarterly comparisons through Sep '19 versus the year ago periods. Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines.'"
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LH - NYSE - HEALTH SERVICES - Medical Laboratories & Researc Laboratory Corp Of Amer	$187.61	+6.57 3.63%	$190.35	$196.36	-4.46%	383,050 54.03%	709,000
Most Recent Note for LH - 3/4/2020 11:09:40 AM Perched near its all-time high after testing its 200 DMA line. Dec '19 quarterly earnings rose +13% on +6% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline. Perched near its all-time high hit on the prior session with a volume-driven gain.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PFSI - NYSE - Finance-Mrtg&Rel Svc Pennymac Fincl Svcs Cl A	$37.04	+0.49 1.33%	$37.21	$39.57	-6.40%	319,454 51.19%	624,000
Most Recent Note for PFSI - 3/4/2020 11:11:15 AM Gapped down on 2/13/20 retreating from its all-time high and recently found support near its 50 DMA line ($34.70) and prior highs. Noted with caution in prior mid-day reports - "Reported earnings +198% on +95% sales revenues for the Dec '19 quarter but fundamental concerns remain. Prior mid-day reports cautioned members - 'Fundamentals (C and A criteria) are not a match with the fact-based investment system's fundamental guidelines.'"
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
QGEN - NASDAQ - DRUGS - Biotechnology Qiagen Nv	$41.50	+0.05 0.11%	$41.70	$43.16	-3.86%	3,252,449 102.44%	3,175,000
Most Recent Note for QGEN - 3/4/2020 11:12:21 AM Quarterly sales revenues and earnings growth history is not a match with the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
REGN - NASDAQ - DRUGS - Biotechnology Regeneron Pharmaceutical	$477.17	+15.62 3.38%	$481.76	$470.00	1.53%	467,682 48.12%	972,000
Most Recent Note for REGN - 3/4/2020 11:13:57 AM Hitting another new 52-week high today. Held its ground stubbornly following volume-driven gains. Prior mid-day reports noted - "Reported earnings +10% on +13% sales revenues for the Dec '19 quarter, and prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Downturn in FY '15 earnings was a noted flaw in its annual earnings (A criteria) history."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SQ - NYSE - Finance-CrdtCard/PmtPr Square Inc	$76.44	-2.40 -3.04%	$78.88	$87.25	-12.39%	4,276,854 48.21%	8,871,000
Most Recent Note for SQ - 3/4/2020 11:14:53 AM Consolidating -12% off its 52-week high following volume-driven gains. Prior mid-day reports cautioned members - "Faces resistance due to overhead supply up to the $101 level. Fundamentals remain strong after it reported earnings +64% on +41% sales revenues for the Dec '19 quarter above the +25% minimum guideline (C criteria). Went through a choppy consolidation since dropped from the Featured Stocks list on 4/25/18."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SYNH - NASDAQ - Medical-Research Eqp/Svc Syneos Health Inc	$71.00	+2.71 3.97%	$71.85	$73.47	-3.36%	378,302 74.47%	508,000
Most Recent Note for SYNH - 3/4/2020 11:16:51 AM Found prompt support at its 50 DMA line and rallied to hit a new 52-week high with big volume-driven gains. Fundamental concerns remain. Noted with caution in prior mid-day reports - "Reported earnings +16% on +6% sales revenues for the Sep '19 quarter. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fundamental guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ZM - NASDAQ - Computer Sftwr-Enterprse Zoom Video Comm Cl A	$113.73	-3.74 -3.18%	$119.97	$121.93	-6.73%	3,414,261 76.26%	4,477,000
Most Recent Note for ZM - 3/4/2020 11:18:39 AM Due to report earnings news while perched near its all-time high. Trading in a wider intra-day range has been noted as an indication of uncertainty after an impressive spurt of volume-driven gains. Rebounded following a deep consolidation. Completed its $36.00 IPO on 4/18/19. Limited annual history (A criteria) is a concern. Quarterly comparisons through Oct '19 showed very strong sales revenues and great earnings increases versus the year ago periods.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ZYXI - NASDAQ - Medical-Products Zynex Inc	$13.96	+0.53 3.95%	$14.47	$14.50	-3.72%	188,580 54.82%	344,000
Most Recent Note for ZYXI - 3/4/2020 11:20:18 AM Trading up today after a negative reversal on the prior session at its 52-week high. Held its ground after a recent spurt of volume-driven gains. Reported earnings +13% on +52% sales revenues for the Dec '19 quarter, and prior quarterly comparisons were below the +25% minimum guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.